{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:57:03Z","timestamp":1780624623532,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG2154"],"award-info":[{"award-number":["RTG2154"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.eplepsyres.2022.106967","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:33:03Z","timestamp":1655260383000},"page":"106967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Intrathecal application of ethosuximide is highly efficient in suppressing seizures in a genetic model of absence epilepsy"],"prefix":"10.1016","volume":"184","author":[{"given":"Anna-Sophia","family":"Buschhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Scherlie\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne G.","family":"de Mooij-van Malsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schiffelholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Stephani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2022.106967_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","article-title":"The role of brain barriers in fluid movement in the CNS: is there a \u2018glymphatic\u2019 system?","volume":"135","author":"Abbott","year":"2018","journal-title":"Acta Neuropathology"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib2","first-page":"2021","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents","author":"Brigo","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/009127006900900607","article-title":"Absorption and elimination of ethosuximide in children","volume":"9","author":"Buchanan","year":"1969","journal-title":"J. Clin. Pharmacol. J. N. Drugs"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib4","article-title":"Transependymal cerebrospinal fluid flow: opportunity for drug delivery?","author":"Casaca-Carreira","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/2045-8118-9-3","article-title":"Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months","volume":"9","author":"Chiu","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","article-title":"Intracerebroventricular delivery as a safe, long-term route of drug administration","volume":"67","author":"Cohen-Pfeffer","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib7","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1592\/phco.29.7.832","article-title":"Intracerebroventricular administration of drugs","volume":"29","author":"Cook","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100326","article-title":"Anti-seizure therapy with a long-term, implanted intra-cerebroventricular delivery system for drug-resistant epilepsy: a first-in-man study","volume":"22","author":"Cook","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ana.410250610","article-title":"Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons","volume":"25","author":"Coulter","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrn811","article-title":"Childhood absence epilepsy: genes, channels, neurons and networks","volume":"3","author":"Crunelli","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1535-7597.2002.00024.x","article-title":"Block of thalamic T-Type Ca2+ channels by ethosuximide is not the whole story","volume":"2","author":"Crunelli","year":"2002","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib12","series-title":"Physiology of the CSF and Blood-brain Barriers","author":"Davson","year":"1996"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneumeth.2015.05.022","article-title":"The genetic absence epilepsy rat from Strasbourg as a model to decipher the neuronal and network mechanisms of generalized idiopathic epilepsies","volume":"260","author":"Depaulis","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0920-1211(91)90055-K","article-title":"Spike-wave discharges and sleep-wake states in rats with absence epilepsy","volume":"9","author":"Drinkenburg","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(06)68477-8","article-title":"Adult epilepsy","volume":"367","author":"Duncan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice**college of pharmacy, University of Nebraska, Lincoln 8","volume":"46","author":"Dunham","year":"1957","journal-title":"J. Am. Pharm. Assoc. Sci. Ed."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib17","doi-asserted-by":"crossref","first-page":"1705328","DOI":"10.1002\/adma.201705328","article-title":"Advances in biomaterials for drug delivery","volume":"30","author":"Fenton","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib18","doi-asserted-by":"crossref","unstructured":"Fleming, A.B., Saltzman, W.M., 2002. Pharmacokinetics of the Carmustine Implant: Clin. Pharmacokinet. 41, 403\u2013419. https:\/\/doi.org\/10.2165\/00003088\u2013200241060-00002.","DOI":"10.2165\/00003088-200241060-00002"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/pharmaceutics12121134","article-title":"Bypassing the blood\u2013brain barrier: direct intracranial drug delivery in epilepsies","volume":"12","author":"Gernert","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/01616412.1995.11740311","article-title":"Anticonvulsant effect of intraventricular antiepileptic drugs. Experimental study","volume":"17","author":"Gonz\u00e1lez-Darder","year":"1995","journal-title":"Neurol. Res."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuropharm.2011.09.006","article-title":"Ethosuximide modifies network excitability in the rat entorhinal cortex via an increase in GABA release","volume":"62","author":"Greenhill","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(99)02089-2","article-title":"Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration","volume":"856","author":"Groothuis","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2009.10.013","article-title":"Localized cortical injections of ethosuximide suppress spike-and-wave activity and reduce the resistance to kindling in genetic absence epilepsy rats (GAERS)","volume":"89","author":"G\u00fclhan Aker","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1528-1157.1995.tb01613.x","article-title":"Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs","volume":"36","author":"Honack","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib25","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1523\/JNEUROSCI.14-09-05485.1994","article-title":"Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects","volume":"14","author":"Huguenard","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ana.410080506","article-title":"Time modulation of spike-and-wave activity in generalized epilepsy","volume":"8","author":"Kellaway","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/fcp.12249","article-title":"SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats","volume":"31","author":"Kordi Jaz","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib29","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.18-13-04842.1998","article-title":"On the action of the anti-absence drug ethosuximide in the rat and cat thalamus","volume":"18","author":"Leresche","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchemneu.2016.01.009","article-title":"An applicable method of drawing cerebrospinal fluid in rats","volume":"74","author":"Li","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1528-1157.1984.tb04199.x","article-title":"Kinetics of penetration of common antiepileptic drugs into cerebrospinal fluid","volume":"25","author":"L\u00f6scher","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib32","first-page":"6","article-title":"Dynamics of networks during absence seizure\u2019s on- and offset in rodents and man","author":"L\u00fcttjohann","year":"2015","journal-title":"Front. Physiol."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuroscience.2003.09.026","article-title":"Cortical-area specific block of genetically determined absence seizures by ethosuximide","volume":"123","author":"Manning","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib34","doi-asserted-by":"crossref","unstructured":"Marescaux, C., Vergnes, M., Depaulis, A., 1992. Genetic absence epilepsy in rats from Strasbourg \u2014 A review, in: Marescaux, C., Vergnes, M., Bernasconi, R. (Eds.), Generalized Non-Convulsive Epilepsy: Focus on GABA-B Receptors. Springer Vienna, Vienna, pp. 37\u201369. https:\/\/doi.org\/10.1007\/978\u20133-7091\u20139206-1_4.","DOI":"10.1007\/978-3-7091-9206-1_4"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib35","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41593-018-0130-4","article-title":"Cortical drive and thalamic feed-forward inhibition control thalamic output synchrony during absence seizures","volume":"21","author":"McCafferty","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib36","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1523\/JNEUROSCI.22-04-01480.2002","article-title":"Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats","volume":"22","author":"Meeren","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/bdd.266","article-title":"The pharmacokinetics of ethosuximide enantiomers in the rat","volume":"22","author":"Mifsud","year":"2001","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF03190184","article-title":"The metabolism of ethosuximide","volume":"18","author":"Millership","year":"1993","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: Bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRX"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1528-1157.1977.tb05001.x","article-title":"Distribution characteristics of ethosuximide in discrete areas of rat brain","volume":"18","author":"Patel","year":"1977","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2005.00326.x","article-title":"Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies","volume":"46","author":"Patsalos","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib43","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1528-1157.1984.tb04180.x","article-title":"Valproic acid-ethosuximide interaction: a pharmacokinetic study","volume":"25","author":"Pisani","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib45","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1523\/JNEUROSCI.0753-07.2007","article-title":"Deep layer somatosensory cortical neurons initiate spike-and-wave discharges in a genetic model of absence seizures","volume":"27","author":"Polack","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-1211(03)00060-3","article-title":"Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy","volume":"54","author":"Richards","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eplepsyres.2006.02.003","article-title":"Effect of intracerebroventricular continuous infusion of valproic acid versus single i.p. and i.c.v. injections in the amygdala kindling epilepsy model","volume":"70","author":"Serralta","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155551","article-title":"New insights on different response of MDMA-elicited serotonin syndrome to systemic and intracranial administrations in the rat brain","volume":"11","author":"Shokry","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib49","doi-asserted-by":"crossref","unstructured":"Teschendorf, H.J.and Kretzschmar, R., 1985. Succinimides, in: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs, Handbook of Experimental Pharmacology. Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 557\u2013574. https:\/\/doi.org\/10.1007\/978\u20133-642\u201369518-6_19.","DOI":"10.1007\/978-3-642-69518-6_19"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib50","doi-asserted-by":"crossref","first-page":"16423","DOI":"10.1523\/JNEUROSCI.2506-11.2011","article-title":"The anticonvulsant response to valproate in kindled rats is correlated with its effect on neuronal firing in the substantia nigra pars reticulata: a new mechanism of pharmacoresistance","author":"Tollner","year":"2011","journal-title":"J. Neurosci"},{"issue":"4","key":"10.1016\/j.eplepsyres.2022.106967_bib51","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"15","author":"Tringham","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0920-1211(88)90042-3","article-title":"Circadian rhythmicity in absence epilepsy in rats","volume":"2","author":"Van Luijtelaar","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.106967_bib53","series-title":"Neurological Disorders: Public Health Challenges","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.8.10.769","article-title":"A new drug for petit mal epilepsy","volume":"8","author":"Zimmerman","year":"1958","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2022.106967_bib55","doi-asserted-by":"crossref","unstructured":"Van Luijtelaar, G., Wiaderna, D., Elants, C., Scheenen, W., 2000. Opposite effects of T- and L-type Ca2q channels blockers in generalized absence epilepsy 9. doi: 10.1016\/s0014-2999(00)00714-7.","DOI":"10.1016\/S0014-2999(00)00714-7"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:48:43Z","timestamp":1760276923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121122001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":55,"alternative-id":["S0920121122001188"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106967","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal application of ethosuximide is highly efficient in suppressing seizures in a genetic model of absence epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106967"}}